Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823043 · ClinicalTrials.gov registry record
A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
A clinical trial, sponsored by Vistakon Pharmaceuticals.
- Completed
- Registry status
- 103
- Enrollment target
NCT00823043 is a clinical trial that has completed, run by Vistakon Pharmaceuticals. The registered enrollment target is 103 participants.
The verdict
NCT00823043 has completed, sponsored by Vistakon Pharmaceuticals.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No treatment was prescribed.
Interventions
- DRUG timolol hemihydrate
- DRUG timolol maleate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823043
The ClinicalTrials.gov registry entry for NCT00823043 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vistakon Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which timolol hemihydrate is the first listed.
NCT00823043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00823043 about?
NCT00823043 is a clinical study titled "A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs". The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No...
What is the current status of trial NCT00823043?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2009-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00823043?
The interventions under investigation include: timolol hemihydrate (DRUG), timolol maleate (DRUG).
Who is sponsoring clinical trial NCT00823043?
This trial is sponsored by Vistakon Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.